Q4 2024 Holdings
Filed 2025-02-14 | 1 holdings | $33.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2025-05-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc.(BCAX) | Common Stock | 055477103 | $38.4M | 2,204,650 | 31.8% |
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $34.8M | 13,072,340 | 28.8% |
| Upstream Bio Inc.(UPB)A | Common Stock | 91678A107 | $33.5M | 2,036,293 | 100.0% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $23.9M | 1,975,203 | 19.8% |
| Lexeo Therapeutics(LXEO) | Common Stock | 52886X107 | $7.8M | 1,184,636 | 6.5% |
| Alumis Inc(ALMS) | Common Stock | 022307102 | $5.1M | 653,223 | 4.3% |
| Ikena Oncology | Common Stock | 45175G108 | $3.7M | 2,249,123 | 3.1% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $3.5M | 526,357 | 2.9% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $1.8M | 1,788,160 | 1.5% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $1.4M | 843,750 | 1.1% |
| enGene Holdings Inc.(ENGNW) | Warrant | 29286M113 | $271.1K | 321,502 | 0.2% |
| Syros Pharmaceuticals(SYRS) | Common Stock | 87184Q206 | $57.8K | 251,270 | 0.0% |